Erika Castro
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
Journal: Swiss medical weekly
Published: March 11, 2021
Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 22, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.
Journal: The International journal on drug policy
Published: July 10, 2018
Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis.
Journal: Journal of viral hepatitis
Published: May 16, 2018
A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTI.
Journal: International journal of STD & AIDS
Published: July 04, 2017
Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs.
Journal: World journal of virology
Published: October 08, 2015
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 13, 2015
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.
Journal: The Journal of antimicrobial chemotherapy
Published: October 23, 2014
HIV-1 superinfection with a triple-class drug-resistant strain in a patient successfully controlled with antiretroviral treatment.
Journal: AIDS (London, England)
Published: June 10, 2014
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.
Journal: The Journal of clinical investigation
Published: January 28, 2014
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
Journal: European journal of immunology
Published: May 22, 2012
Last Updated: 09/26/2026